There is no Press for this Ticker
Sector: Health Care.Industry: Biotechnology
Achaogen Inc is a biopharmaceutical company developing novel antibacterial treatments against multi-drug resistant gram-negative infections. The company is researching and developing on its product plazomicin used for the treatment of serious bacterial infections. It's another antibacterial candidate, C-Scape treats patients with urinary tract infections. All of the company's revenue is generated from government contracts for research and development in the United States.

Analyst Ratings

see more
DateAnalyst FirmAnalyst NameActionRatingAction Price Prior Price Target

Related Companies

TickerCompanyChg %Mkt Cap
AKAOQAchaogen-17.34%

Achaogen Frequently Asked Questions

Q

How do I buy Achaogen (AKAOQ) stock?

A

You can purchase shares of Achaogen (OTC: AKAOQ) through any online brokerage.

View our list of the best stock brokerages.

Q

Who are Achaogen's (AKAOQ) competitors?

A

There are no as such competitors for Achaogen.

Q

What is the target price for Achaogen (AKAOQ) stock?

A

The latest price target for Achaogen (OTC: AKAOQ) was reported by SunTrust Robinson Humphrey on November 13, 2018. The analyst firm set a price target for 3.00 expecting AKAOQ to rise to within 12 months (a possible 14534.15% upside). 0 analyst firms have reported ratings in the last year.

Q

Current Stock Price for Achaogen (AKAOQ)?

A

The stock price for Achaogen (OTC: AKAOQ) is $0.0205 last updated Today at 4:56:32 PM.

Q

Does Achaogen (AKAOQ) pay a dividend?

A

There are no upcoming dividends for Achaogen.

Q

When is Achaogen (OTC:AKAOQ) reporting earnings?

A

Achaogen does not have any upcoming earnings scheduled.

Q

Is Achaogen (AKAOQ) going to split?

A

There is no upcoming split for Achaogen.

Q

What sector and industry does Achaogen (AKAOQ) operate in?

A

Achaogen is in the Consumer Discretionary sector and Multiline Retail industry. They are listed on the OTC.